FluoroPharma Medical, Inc.

8 Hillside Avenue, Suite 207
Montclair, NJ 07042 USA
Click for website

Research Sector Diagnostics

Summary Description Develops, sells and researches diagnostic & imaging products.

Management Thijs Spoor, CEO; Boyan Goumnerov, MD, COO & Vice President Clinical Trials; Tamara Rhein, CFO

Click here for Financial Data
Keywords: Diagnostics, Imaging, cadio, cardiovascular, tech, development, molecular, emmissions, novel, disease, detection


Updated: Oct. 22, 2015


FluoroPharma Medical, Inc., engages in the discovery, development and commercialization of proprietary medical diagnostic imaging products. The companys initial focus is the development of breakthr......view more

Technology / Differentiation

FluoroPharmas technology consists of novel molecular PET agents for the cardiovascular, oncology and neurology arenas. The most advanced programs are in the area of cardiology where the agents h...view more

Market / Customers

FluoroPharmas products utilize positron emission tomography (PET) technology, a molecular imaging platform that is growing rapidly due to its inherently superior sensitivity and specificity compare......view more